Two River and Vida Ventures Extend Track Record of Company Creation and Value Realization Following the Candid Therapeutics’ Acquisition by UCB Two River, LLC and Vida Ventures both part of the Bellco Health ecosystem, acknowledged the announced acquisition of Candid…
UCB to Acquire Candid Therapeutics, Building Upon Its Existing Immunology Pipeline With Novel T-cell Engagers UCB, a global biopharmaceutical company, announced signing of a definitive agreement under which it would acquire Candid Therapeutics (Candid), a privately held clinical-stage biotechnology company…
Sequenex Announces Partnership with MedTech Innovator, Industry’s Leading Startup Accelerator Sequenex announced its partnership with MedTech Innovator (MTI), the world’s largest accelerator of medical technology companies. MedTech Innovator matches healthcare industry leaders with innovative early-stage medtech companies for mentorship and…
Chemical Reduction Solutions LLC Expands Partnership with Simoniz USA Inc. to Exclusively Commercialize Nanobubble Technology in the Car Wash Industry Chemical Reduction Solutions LLC (“CRS”), a developer of hydrodynamic cavitation-based nanobubble technology, today announced an expanded partnership with Simoniz USA…
SK Capital Partners Completes Sale of Noramco, Extractas Biosciences, and Purisys to Siegfried Holding AG Affiliates of funds advised by SK Capital Partners, LP a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today…
ŌURA Closes the Hormonal Health Data Gap ŌURA, maker of the world’s leading smart ring, announced two new experiences designed to help women navigate the hormonal shifts that shape most of their lives: Hormonal Birth Control support and Menopause Insights.…
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® (plozasiran) in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome (FCS) Arrowhead Pharmaceuticals, Inc. announced that the Australian Therapeutic Goods Administration (TGA) has approved REDEMPLO® (plozasiran), a small interfering RNA (siRNA) medicine,…
Nebius Agrees to Acquire Eigen AI, Strengthening Nebius Token Factory as a Frontier Inference Platform Nebius the AI cloud company, announced an agreement to acquire Eigen AI, a leading inference and model optimization company. The acquisition will strengthen Nebius Token Factory…
TRUQAP® (capivasertib)recommended by FDA Advisory Committee for PTEN-deficient metastatic hormone-sensitive prostate cancer The US Food and Drug Administration’s Oncologic Drugs Advisory Committee has recognized a favorable benefit risk profile for AstraZeneca’s TRUQAP® (capivasertib) in combination with abiraterone and androgen deprivation therapy…
ProNatural Brands Announces Strong Growth, Amazon Expansion, and Accelerating Consumer Demand for Natural Cleaning Solutions ProNatural Brands announced continued strong growth and expanding market momentum as demand rises for safer, more sustainable cleaning and disinfecting solutions. Founded in 2012, ProNatural…
Availity’s Inaugural Abrasion Index Reveals Where Payer-Provider Friction Hits Healthcare Hardest Availity®, the nation’s largest health information network, today released its first annual Availity Abrasion Index, a research-informed report that measures where administrative friction between health plans and providers is highest…
Sunnybrook Announces $41-Million Gift to Advance Canada’s Global Leadership in Clinical Trials Sunnybrook Health Sciences Centre is proud to announce a $41M philanthropic investment in Sunnybrook Clinical Trials. The investment expands dedicated infrastructure, capacity and expertise across Sunnybrook to optimize how clinical…